Danielle Vanasse

Safety and feasibility of anti-CD19 CAR T cells with fully human binding domains in patients with B-cell lymphoma

Jennifer N. Brudno, Norris Lam, Danielle Vanasse et al. · Nature Medicine · 2020 · 314 citations · Full text

Life Sciences, Hematology, Immunology +12

Long-Term Follow-Up of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy

Kathryn M. Cappell, Richard M. Sherry, James C. Yang et al. · Journal of Clinical Oncology · 2020 · 308 citations · Full text

Medicine, Hematology, Oncology +16

Development of CAR T Cells Expressing a Suicide Gene Plus a Chimeric Antigen Receptor Targeting Signaling Lymphocytic-Activation Molecule F7

Christina Amatya, Melissa A. Pegues, Norris Lam et al. · Molecular Therapy · 2020 · 101 citations · Full text

Life Sciences, Immunology, Oncology +17

T Cells Expressing an Anti-B-Cell Maturation Antigen (BCMA) Chimeric Antigen Receptor with a Fully-Human Heavy-Chain-Only Antigen Recognition Domain Induce Remissions in Patients with Relapsed Multiple Myeloma

Lekha Mikkilineni, Elisabet E. Manasanch, Norris Lam et al. · Blood · 2019 · 46 citations

Life Sciences, Hematology, Immunology +17

Deep and Durable Remissions of Relapsed Multiple Myeloma on a First-in-Humans Clinical Trial of T Cells Expressing an Anti-B-Cell Maturation Antigen (BCMA) Chimeric Antigen Receptor (CAR) with a Fully-Human Heavy-Chain-Only Antigen Recognition Domain

Lekha Mikkilineni, Elisabet E. Manasanch, Danielle Vanasse et al. · Blood · 2020 · 20 citations

Life Sciences, Immunology, Oncology +16